Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) May Be Attracting Institutional Investments

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

Aurinia Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Aurinia Pharmaceuticals Inc is $1.17B. A total of 0.86 million shares were traded on the day, compared to an average of 1.45M shares.

In the most recent transaction, TANG KEVIN bought 500,000 shares of AUPH for 9.09 per share on Dec 09 ’24. After the transaction, the Director now owns 8,429,500 company shares. In a previous transaction on Dec 06 ’24, TANG KEVIN bought 400,000 shares at 9.01 per share. AUPH shares that Director owns now total 7,929,500.

Among the insiders who bought shares, TANG KEVIN acquired of 300,000 shares on Dec 05 ’24 at a per-share price of $8.91. This resulted in the Director holding 7,529,500 shares of AUPH after the transaction. In another insider transaction, Bailey Jeffrey Allen sold 4,557 shares at $8.43 per share on Nov 11 ’24. Company shares held by the Director now total 13,356.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, AUPH has a high of $10.67 and a low of $4.71.

As of this writing, AUPH has an earnings estimate of $0.0 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of $0.16 per share and a lower estimate of -$0.09.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. AUPH’s latest balance sheet shows that the firm has $466.08M in Cash & Short Term Investments as of fiscal 2021. There were $8.74M in debt and $40.65M in liabilities at the time. Its Book Value Per Share was $2.71, while its Total Shareholder’s Equity was $479.09M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AUPH is Buy with a score of 4.43.

Most Popular

Related Posts